Translational Research in Systemic Vasculitis

系统性血管炎的转化研究

• 批准号: 6556849
• 负责人: John H Stone
• 金额: $ 8.13万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6556849
• 关键词: Wegener's granulomatosis; biomarker; clinical research; cytokine; diagnosis design /evaluation; diagnosis quality /standard; human subject; informatics; mass spectrometry; pathologic process; patient oriented research; phenotype; protein quantitation /detection; protein structure function; proteomics; remission /regression; rheumatism; statistics /biometry; vasculitis

DESCRIPTION (provided by applicant): Systemic vasculitis is a group of inflammatory disorders of blood vessels. Because knowledge of the pathophysiology of these conditions remains incomplete, their treatments are empiric, toxic, and often unsuccessful in inducing durable remissions. Insights derived from this translational research program described by Dr. John Stone, Director of the Johns Hopkins Vasculitis Center, may lead to novel methods of evaluating vasculitis patients. Dr. Stone's mentoring program for junior investigators interested in translational research provides access to a large database of well-characterized patients with vasculitis, outstanding institutional resources for clinical research training, committed mentoring, well-established collaborations within and outside of Johns Hopkins, and a research infrastructure that is essential to career development. As a programmatic research goal in the context of this application, Dr. Stone will employ current funding and existing collaborations to develop his work in proteomics. His co-investigators in this effort are collaborators at the National Cancer Institute/Food & Drug Administration (NCI/FDA) Clinical Proteomics Program, Dr. Emanuel Petricoin and Dr. Lance Liotta. Funding from the Maryland Arthritis Research Consortium (MARRC) and from the Food & Drug Administration's Office of Orphan Products Development will support these studies. The initial disease focus of this work will be Wegener's granulomatosis, using sera collected in the Wegener's Granulomatosis Etanercept Trial (A multicenter, NIAMS-funded trial in which Dr. Stone is the Principal Investigator). Other areas of research at the Vasculitis Center on which young investigators may choose to focus include: 1) the investigation of novel therapeutic approaches; 2) the role of microbial pathogens in the etiology of vasculitis; and, 3) molecular mechanisms of systemic vasculitis (under co-mentoring arrangements with colleagues whose expertise complements that of Dr. Stone), using patient samples and clinical data from the Vasculitis Center.

描述（由申请人提供）：系统性血管炎是一组血管炎性疾病。由于对这些疾病的病理生理学的了解仍然不完整，它们的治疗是经验性的、有毒的，并且在诱导持久缓解方面往往不成功。约翰·霍普金斯血管炎中心主任约翰·斯通博士描述的这一转化研究项目中得出的见解可能会带来评估血管炎患者的新方法。Stone博士的指导计划为对转化研究感兴趣的初级研究人员提供了访问血管炎患者的大型数据库，用于临床研究培训的优秀机构资源，致力于指导，约翰霍普金斯内外的良好合作，以及对职业发展至关重要的研究基础设施。 作为本申请背景下的计划性研究目标，Stone博士将利用当前的资金和现有的合作来发展他在蛋白质组学方面的工作。他在这项工作中的合作研究者是国家癌症研究所/食品和药物管理局（NCI/FDA）临床蛋白质组学项目的合作者，Emanuel Petricoin博士和Lance Liotta博士。由马里兰州关节炎研究联盟（MARRC）和食品和药物管理局孤儿产品办公室资助 发展将支持这些研究。这项工作的初始疾病重点将是韦格纳肉芽肿病，使用韦格纳肉芽肿病依那西普试验（一项多中心，NIAMS资助的试验，其中Stone博士是主要研究者）中收集的血清。血管炎中心的其他研究领域，年轻的研究人员可以选择集中在：1）新的治疗方法的调查; 2）微生物病原体在血管炎病因学中的作用;系统性血管炎的分子机制（根据与同事的共同指导安排，这些同事的专业知识与斯通博士的专业知识互补），使用来自血管炎中心的患者样本和临床数据。